Accelerated TMS for Hand Dystonia
Trial Summary
What is the purpose of this trial?
This study aims to investigate the impact of accelerated transcranial magnetic stimulation (TMS) on brain function and behavior in patients with focal hand dystonia. Previous research demonstrated that individualized TMS improved dystonic behavior after one session. Building on this, the current study administers four TMS sessions in a day, with assessments conducted in four weeks, twelve weeks, and 20 weeks after each session. The research involves 8 in-person and 6 virtual visits focused on functional MRI brain scans and writing behavior analysis. The potential risk of seizures from TMS is mitigated through careful screening, adhering to safety guidelines. The study's main benefit is enhancing dystonic behavior and deepening the understanding of brain changes caused by TMS in focal hand dystonia, paving the way for further advancements in clinical therapy for this condition.
Will I have to stop taking my current medications?
Yes, you will need to stop taking medications used for treating dystonia symptoms, such as anticholinergics, benzodiazepines, and muscle relaxants, at least one month before the study.
What data supports the effectiveness of the treatment Accelerated TMS for Hand Dystonia?
Research shows that theta burst stimulation, a component of Accelerated TMS, can lead to improvements in dystonia symptoms by modifying brain circuits involved in movement control. In cervical dystonia, a similar condition, cerebellar theta burst stimulation resulted in a small but significant clinical improvement, suggesting potential benefits for hand dystonia as well.12345
Is Accelerated TMS generally safe for humans?
Research on repetitive transcranial magnetic stimulation (rTMS) and related techniques like Theta-Burst Stimulation shows they are generally safe for humans, with studies often focusing on conditions like dystonia. While these studies primarily assess effectiveness, they also monitor safety, and no major safety concerns have been reported in the context of these treatments.35678
How does the treatment Accelerated TMS differ from other treatments for hand dystonia?
Accelerated TMS (repetitive transcranial magnetic stimulation) is unique because it uses magnetic fields to stimulate specific brain areas, potentially improving brain plasticity and connectivity, which are often altered in dystonia. Unlike traditional treatments, it targets the brain's motor and sensory pathways non-invasively, offering a novel approach to managing symptoms.12359
Eligibility Criteria
This trial is for adults over 18 with isolated focal hand dystonia, confirmed by a neurologist. Participants must be right-handed, able to give informed consent and literate. Excluded are those with other movement disorders or seizure history, recent drug use or certain treatments like TMS therapy, botulinum toxin injections, specific medications for dystonia symptoms, and recent hand therapy.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive accelerated TMS sessions, with four sessions administered in a single day
Assessment
Participants undergo functional MRI brain scans and engage in writing tasks to evaluate changes in brain function and behavior
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 12, 20, 24, 32, and 40 weeks
Treatment Details
Interventions
- Accelerated TMS (Procedure)
Accelerated TMS is already approved in United States, European Union, United Kingdom for the following indications:
- Major Depressive Disorder
- Obsessive Compulsive Disorder
- Major Depressive Disorder
- Obsessive Compulsive Disorder
- Major Depressive Disorder
- Obsessive Compulsive Disorder
- Post-Traumatic Stress Disorder
- Depersonalization Disorder
- Borderline Personality Disorder
- Addiction